UBS downgrades Ormat Technologies to Neutral and cuts price target to $100
UBS lowered its rating on Ormat Technologies (ORA) from Buy to Neutral and reduced its price target from $157 to $100. The downgrade was driven by the company’s own revision that trimmed FY 2028 adjusted EBITDA guidance by 3% and lowered the four‑year revenue growth outlook for its energy‑storage segment. UBS also expects adjusted EBITDA growth to slow to 9% in 2027 from 13% in 2026. The analyst’s view caused the stock to fall between 1.9% and 4.5% on the day.
Why it matters
The lower rating and target suggest limited earnings upside through 2028, which may pressure the share price further. UBS’s revised growth assumptions also signal slower future cash‑flow generation for investors.
Key facts
- 1UBS cut the price target to $100 from $157. investing.com
- 2Ormat trimmed FY 2028 adjusted EBITDA guidance by 3%. investing.com
- 3UBS reduced the four‑year revenue CAGR estimate for the energy‑storage segment to 24% from 32% for 2026‑2030. investing.com
- 4UBS now forecasts adjusted EBITDA growth of 9% in 2027, down from 13% in 2026. investing.com
- 5The stock closed at $91.49 on the day of the downgrade. marketscreener.com
- 6Shares fell to a session low of $87.07, a new 52‑week low, below the 52‑week high of $146.39. investing.com
Summary written by AlphAI from 8 of 8 sources. Not investment advice. Figures are as stated by the linked sources.